The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus

J E Strong1, M C Coffey, D Tang

  • 1Department of Microbiology and Infectious Diseases, University of Calgary Health Sciences Centre, Calgary, Alberta, Canada T2N 4N1.

The EMBO Journal
|June 17, 1998
PubMed

Insights

NIH-3T3 cells resist reovirus infection until Ras transformation. This transformation blocks viral protein synthesis inhibition by double-stranded RNA-activated protein kinase (PKR), enabling viral replication and oncolysis.

Area of Science:

  • Virology
  • Cell Biology
  • Molecular Biology

Background:

  • NIH-3T3 cells exhibit resistance to reovirus infection.
  • Viral proliferation is restricted at the protein synthesis level, not transcription.
  • Transformation with Ras or Sos confers susceptibility to reovirus.

Purpose of the Study:

  • To investigate the mechanism of reovirus resistance in NIH-3T3 cells.
  • To identify the cellular factors involved in reovirus replication control.
  • To elucidate the role of the Ras signaling pathway in reovirus oncolysis.

Main Methods:

  • Cell transformation using activated Sos or Ras.
  • Analysis of viral gene transcription and protein synthesis.
  • Identification and characterization of a 65 kDa phosphorylated protein in cell lysates.
  • Inhibition of protein kinase R (PKR) phosphorylation using 2-aminopurine or gene deletion.

Main Results:

  • Transformed NIH-3T3 cells (Sos or Ras) became susceptible to reovirus.
  • Reovirus proliferation was inhibited at the protein synthesis stage in untransformed cells.
  • A 65 kDa protein, identified as double-stranded RNA-activated protein kinase (PKR), was phosphorylated in infected untransformed cells, inhibiting translation.
  • PKR phosphorylation was blocked in transformed cells, allowing viral protein synthesis.
  • Inhibition of PKR phosphorylation enhanced reovirus protein synthesis in untransformed cells.

Conclusions:

  • Reovirus infection triggers PKR phosphorylation in untransformed cells, inhibiting viral translation.
  • The Ras signaling pathway in transformed cells blocks PKR phosphorylation, facilitating viral protein synthesis.
  • Ras pathway usurpation is the basis for reovirus oncolysis.

Related Concept Videos

Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...